-
-
-
-
-
-
-
Evolus (EOLS) PT Lowered to $15 at Mizuho
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Evolus (EOLS)
-
-
-
-
-
-
-
Evolus submits FDA application for Evolysse Sculpt dermal filler
-
-
-
-
-
-
-
Mizuho on Evolus (EOLS): 'We recommend buying on any potential weakness'
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Evolus (EOLS)
-
-
-
-
-
-
-
Evolus (EOLS) Announces EU Approval of Estyme Injectable Hyaluronic Acid Gels Under New Medical Device Regulation
-
-
-
-
-
-
-
Evolus (EOLS) Appoints Albert G. White III to its Board
-
445,862 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

